UID

Name/Age/Sex Treating Dr.

012304220065
Mr. EUGENIO ELEVADO 63 YRS/MALE
Dr. SELF

Time of Registration Time of Collection Report Date

29/Jan/2024
29/Jan/2024 11:20AM

29/Jan/2024

HAEMATOLOGY
Test Name Result Unit Ref. Range
Hb A1C 6.30 % Less than 5.7 %
Mean Blood Glucose 132.00 mg/dL

Comments:

The hemoglobin A1c test also called HBA1c, glycated hemoglobin test or glycohemoglobin - is the important
test for assessment of long term glucose control (also called Glycemic control) and is a better indication of long
term glycemic control as than blood glucose determination. Hemoglobin A1c provides an average of your
blood sugar conrol over a six to twelve week period. people with diabetes should have this test every three
months to determine whether their blood sugars have reached the target level of control.

Result A1C

Normal Less than 5.7 %

Prediabetes 5.7 % to 6.4 %

Diabetes 6.5 % or higher

UID

Name/Age/Sex Treating Dr.

012304220065
Mr. EUGENIO ELEVADO 63 YRS/MALE
Dr. SELF

Time of Registration Time of Collection Report Date

29/Jan/2024
29/Jan/2024 11:20AM

29/Jan/2024

Test Name Result Unit Ref.

Range
BIO
CHEMISTR
Y BLOOD
GLUCOSE
FASTING
BLOOD SUGAR FASTING 102.80 mg/dL 74-109
Method: Hexokinase

UID

Name/Age/Sex Treating Dr.

012304220065
Mr. EUGENIO ELEVADO 63 YRS/MALE
Dr. SELF

Time of Registration Time of Collection Report Date

29/Jan/2024
29/Jan/2024 11:20AM
 29/Jan/2024

Test Name Result Unit Ref. Range

LFT,LIVER FUNCTION TEST
TOTAL BILIRUBIN 0.51 mg/dL 0.0-2.0
CONJUGATED BILIRUBIN 0.18 mg/dL 0.0-0. 2
UNCONJUGATED BILIRUBIN(INDIRECT) 0.26 mg/dL
SGOT (AST) 30.10 U/L 0-35
SGPT (ALT) 27.80 U/L 0-45
TOTAL PROTEIN 7.34 g/dL 6.4-8.3
Method: Biuret Gen 2 monochromatic

ALBUMIN,SERUM 4.46 g/dL 3.5-5.2

Method: BCG

GLOBULIN 2.88 gm/dL 2.1-3.5

A/G Ratio 1.65 1.6-2.0
ALKALINE PHOSPHATASE 83.0 U/L 53-128
COMMENTS:

Liver panel test results are not diagnostic of a specific condition. In a person who does not have symptoms or identifiable risk factors, abnormal liver test

results may indicate a temporary liver injury or reflect something that is happening elsewhere in the body - such as in the skeletal muscles, pancreas, or

heart. It may also indicate early liver disease and the need for further testing and/or periodic monitoring.

Results of liver panels are usually evaluated together. Several sets of results from tests performed over a few days or weeks are often assessed together to

determine if a pattern is present. Each person will have a unique set of test results that will typically change over time. The combination of liver test results is

evaluated to gain clues about the underlying condition.

Suspected type of liver Other or follow-up

disorder tests

Viral infection Hepatitis HYPER LINK

"ht t p: / / l a bt e s t s online.

org/ unde rs t a ndi ng/ana

l yt e s / he pa t i t i s -a "

HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/hepa

titis-a"A HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/hepa

titis-a", HYPERLINK

"http://labtestsonline.or
 g/understanding/analyte

s/hepatitis-a"

HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/hepa

titis-b"B HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/hepa

titis-b", HYPERLINK

"http://labtestsonline.org/

understanding/analytes/h

epatitis-b" C, or E

Alcohol abuse/hepatitis GGT HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/ggt",

Ethano HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/etha

nol"l

Autoimmune ANA HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/ana"

, ASMA

Chronic Liver biopsy

Liver cancer AFP HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/afp-

tumor", HYPERLINK

"http://labtestsonline.o

rg/understanding/analyt

es/afp-tumor"

HYPERLINK

"http://labtestsonline.org/u

nderstanding/analytes/dcp"

DCP
Often, further testing is necessary to determine what is causing the liver damage and/or disease. Depending on the results of the liver panel and other factors such

as signs symptoms and clinical and family history, following tests are ordered for specific diagnosis.

UID

Name/Age/Sex Treating Dr.

012304220065
Mr. EUGENIO ELEVADO 63 YRS/MALE
Dr. SELF

Time of Registration Time of Collection Report Date

29/Jan/2024
29/Jan/2024 11:20AM

29/Jan/2024

Test Name Result Unit Ref.

Range

KFT, KIDNEY FUNC TION TEST

BLOOD UREA 24.50 mg/dL 16.6-45.0
Serum
CREATININE,SERUM 0.93 mg/dL 0.7-1.3
Serum
URIC ACID 6.80 mg/dL 3.5-7.2
Serum
BLOOD UREA NITROGEN 11.45 mg/dL 6 .0-20.0
Serum
SODIUM, 139.00 mmol/L 135-145
Serum
POTASSIUM 4.0 mmol/L 3.5-5.5
Serum
CHLORIDE 106.00 mmol/L
Serum
CALCIUM 9.30 mg/dL 8.6-10.2

COMMENTS:
Increased urea & creatinine levels in the blood suggest diseases or conditions that affect kidney function. These can include:

Damage to or swelling of blood vessels in the kidneys (glomerulonephritis) caused by, for example, infection or autoimmune

diseases Bacterial infection of the kidneys (pyelonephritis), prostate disease, kidney stone, or other causes of urinary tract

obstruction
Death of cells in the kidneys' small tubes (acute tubular necrosis) caused by, for example, drugs or toxins

Reduced blood flow to the kidney due to shock, dehydration HYPERLINK "http://labtestsonline.org/understanding/conditions/dehydration/",
HYPERLINK "http://labtestsonline.org/understanding/conditions/dehydration/" HYPERLINK
"http://labtestsonline.org/understanding/conditions/chf"congestive H Y P E R L I N K
" h t t p : / / l a b t e s t s o n l i n e . o r g / u n d e r s t a n d i n g / c o n d i t i o n s / c h f " HYPERLINK
"http://labtestsonline.org/understanding/conditions/chf"heart H Y P E R L I N K
" h t t p : / / l a b t e s t s o n l i n e . o r g / u n d e r s t a n d i n g / c o n d i t i o n s / c h f " HYPERLINK
"http://labtestsonline.org/understanding/conditions/chf"failure HYPERLINK "http://labtestsonline.org/understanding/conditions/chf", HYPERLINK
"http://labtestsonline.org/understanding/conditions/chf" HYPERLINK "http://labtestsonline.org/glossary/atherosclerosis"atherosclerosis
HYPERLINK "http://labtestsonline.org/glossary/atherosclerosis", or complications of diabetes

NOTE:

BUN concentrations may be elevated when there is excessive protein catabolism increased protein in diet, or gastrointestinal

bleeding. Creatinine blood levels can also increase temporarily as a result of muscle injury and are generally slightly

lower during pregnancy HYPERLINK "http://labtestsonline.org/understanding/wellness/pregnancy".

Low blood levels of BUN and creatinine are not common, but they are also not usually a cause for concern.

UID

Name/Age/Sex Treating Dr.

012304220065
Mr. EUGENIO ELEVADO 63 YRS/MALE
Dr. SELF

Time of Registration Time of Collection Report Date

29/Jan/2024
29/Jan/2024 11:20AM

29/Jan/2024
Test Name Result Unit Ref. Range
LIPID PROFILE
CHOLESTEROL 182.0 mg/dL < 200.0
TRIGLYCERIDE 131.60 mg/dL <150.0
HDL-CHOLESTEROL 51.30 mg/dL >40.0
LDL CHOLESTEROL 123.18 mg/dl 40-130
VLDL 28.52 mg/dL 0.0-30.0
LDL / HDL RATIO 2.40 0.0-3.55
TOTAL CHOLESTEROL /HDL RATIO 3.54 0.0-4.5

Comments

Triglyceride levels > 250mg/dL are associated with an approximately 2-fold greater risk of coronary vascular
disease. Elevation of triglycerides can be seen with obesity, medication, fasting less than 12 hrs, alcohol
intake & diabetes mellitus.

Cholesterol, its fractions and triglycerides are the important plasma lipids in defining cardiovascular risk
factors and in the managment of cardiovascular disease. Values above 220 mg/dl are associated with increased
risk of CHD regardless of HDL & LDL values.
HDL-Cholesterol level <35 mg/dL is associated with an increased risk of coronary vascular disease even in
the face of desirable levels of cholesterol and LDL - cholesterol.
LDL - Cholesterol & Total Cholesterol levels can be strikingly altered by thyroid, renal and liver disease as
well as hereditary factors. There are three risk categories :-

CHOLESTEROL LDL-CHOLESTEROL CHOL/HDL RATIO

Acceptable/Low Risk < 200 mg/dL <130 mg/dL < 4.5
Borderline High Risk 200-239 mg/dL 130-159 mg/dl 4.5 - 6.0
High Risk > 240 mg /dL > 160 mg/dL > 6.0

***
End
Of
Rep
ort
***